Joe John Stephenson, Jr., MD
Fax: (864) 404-2011
About us
Joe J. Stephenson, MD, is the Medical Director of the Center for Integrative Oncology and Survivorship (CIOS) and the Center for Cancer Prevention and Wellness (CCPW) at Prisma Health Cancer Institute in Greenville, SC. He is also a practicing medical oncologist, board certified in hematology and oncology. Dr Stephenson is also the co-director of the Prisma Health Breast Cancer Program as well as the Breast Cancer Prevention Program at Prisma Health Cancer Institute in the Upstate. He currently is the Chair of the Prisma Health Cancer Care Committee.
Dr. Stephenson is almost a native of South Carolina. He spent most of his formative years in the state and then attended the Medical University of South Carolina. He went on to his residency at Eisenhower Army Medical Center in Augusta, GA. He performed his fellowship in Hematology and Oncology at Brooke Army Medical Center in San Antonio, Texas. He remained in San Antonio where he held the dual position of Associate Professor at the University of Texas San Antonio School of Medicine and the Cancer Therapy Research Center and was the Director of the General Maxwell Thurman Drug Development Unit.
Dr Stephenson came back to South Carolina taking a position at the Cancer Center of the Carolinas (CCC) in 2000. He served as president of the joint Policy Board for CCC from 2003-2005. Dr. Stephenson is the co-founder of the Prisma Health Institute for Translational Oncology Research (ITOR), a major pillar of cancer research at Prisma Health that includes a Phase I Clinical Research Unit and a Biorepository Services platform. Dr. Stephenson was honored to serve as an advisor to the President Bush’s Cancer Panel on Translational Oncology.
Dr Stephenson is passionate about delivering holistic and individualized care to each patient. He is a champion for breast cancer prevention and an advocate for improving cancer surveillance for cancer survivors and community screening.
Dr Stephenson and his wife Nancy reside in Greenville, SC with their Saint Bernard, Carly. He has two adult sons, Joe, and Connor, both pursuing medical careers. He enjoys working outdoors, fly fishing, and reading about history. He is a big fan of Abe Lincoln. Dr. Stephenson is a member of the Buncombe Street Methodist Church in Greenville on Buncombe Street. He is a big supporter of the youth ministries at UMC and Apologetics.
| Tags | breast cancer immunotherapy, adamantinoma, adjuvant chemotherapy, adult stem cell collection for transplant, adverse effects to anticoagulants, alveolar soft part sarcoma, amyloidosis, anaplastic cancer of thyroid, anemia, anemia of chronic disease, anemia of pregnancy, antithrombin deficiency, aplastic anemia, b12 deficiency anemia, biological targeted therapy, bladder cancer genomics, bleeding disorder, blood cancer, blood disorders, bone marrow disorders, bone sarcoma, brain cancer genomics, breast cancer genetics, cancer, cancer chemotherapy, cancer during pregnancy, cancer genomics, cancer pain, cancer rehabilitation, cancer survivor, cancer related fatigue, cardio oncology, castleman's disease, cervical cancer genomics, cervical teratoma, chemoradiation, colon cancer genomics, cooley anemia, cowden syndrome, cryoglobulinemia, diamond blackfan anemia, diffuse intrinsic pontine glioma (dipg), early detection of cancer, purpura, radionuclide therapy, rectal cancer genomics, reduced intensity conditioning regimens, renal cancer genomics, retroperitoneal mass, rh incompatibility, sacrococcygeal teratoma, sarcoma genomics, secondary polycythemia, side effects of cancer treatment, skin cancer genomics, splenomegaly, stomach cancer, stomach cancer genomics, submucosal tumors, sweat gland carcinoma, tectal glioma, thalassemia, thrombocytopenia, thrombocytosis, thrombophilia, thyroid cancer genomics, endocrine complications of cancer therapy, endometrial cancer, endometrial cancer genomics, epithelioid hemangioendothelioma, factor v leiden, familial aplastic anemia, fanconi anemia, fibrosarcoma of the head & neck, follicular cancer of thyroid, gallbladder cancer genomics, gastrointestinal (gi) cancer genomics, genitourinary cancer genomics, giant cell tumor of the bone, glucose 6 phosphate dehydrogenase deficiency, head and neck cancer, head and neck cancer genomics, hellp syndrome, hemochromatosis, hemoglobinopathies, hemolytic anemia, hemolytic uremic syndrome, heparin induced thrombocytopenia, hereditary cancer risk, hereditary spherocytosis, histiocytosis, hypogammaglobulinemia, idiopathic thrombocytopenic purpura, cancer immunotherapy, iron deficiency anemia, langerhans cell histiocytosis, leukemia genomics, leukopenia, li fraumeni syndrome, liver cancer genomics |